From Proteopedia

Jump to: navigation, search

Caption for this structure

Drag the structure with the mouse to rotate


  1. Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci. 2008 Sep 20;11(2):81s-110s. PMID:19203472 doi:10.18433/j3t886
  2. Kakuta H, Zheng X, Oda H, Harada S, Sugimoto Y, Sasaki K, Tai A. Cyclooxygenase-1-selective inhibitors are attractive candidates for analgesics that do not cause gastric damage. design and in vitro/in vivo evaluation of a benzamide-type cyclooxygenase-1 selective inhibitor. J Med Chem. 2008 Apr 24;51(8):2400-11. PMID:18363350 doi:10.1021/jm701191z
  3. Kopp MA, Liebscher T, Niedeggen A, Laufer S, Brommer B, Jungehulsing GJ, Strittmatter SM, Dirnagl U, Schwab JM. Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury. Cell Tissue Res. 2012 Jul;349(1):119-32. PMID:22350947 doi:10.1007/s00441-012-1334-7
  4. Luo M, Li YQ, Lu YF, Wu Y, Liu R, Zheng YR, Yin M. Exploring the potential of RhoA inhibitors to improve exercise-recoverable spinal cord injury: A systematic review and meta-analysis. J Chem Neuroanat. 2021 Jan;111:101879. PMID:33197553 doi:10.1016/j.jchemneu.2020.101879

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, David Canner

Personal tools